Considerations and Treatment Options for Patients withComorbid Atrial Fibrillation and Diabetes Mellitus.

In conclusion, coexisting AF and DM represent a high risk population of patients requiring aggressive risk factor identification and treatment optimisation. The multifactorial interplay between these conditions requires individual assessment of patient risk profiles with the aim of minimising the impact of each modifiable risk factor. PMID: 28669216 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28669216?dopt=Abstract

Source: Expert Opinion on Pharmacotherapy - July 5, 2017 Category: Drugs & Pharmacology Tags: Expert Opin Pharmacother Source Type: research